In the BioHarmony Drug Report Database
[FDA 2021 Drug Approvals]
Includes access to the collection of FDA 2021 Novel Drug Approval, including all current and future drug reports in the set (within a given subscription period).
The [FDA 2021 Novel Drug Approval] data set contains over 10 drug reports.
One example of an included drug report data is shown below for Casimersen.
Trade Name
|
Amondys 45 |
|---|---|
Common Name
|
Casimersen |
ChEMBL ID
|
CHEMBL4297566 |
Indication
|
|
Drug Class
|
Antisense oligonucleotides |
Image (chem structure or protein)
